Cephalon To Buy Swiss Drugmaker Mepha For $590M
Cephalon Inc. has agreed to pay about $590 million (622.5 million Swiss francs) for the privately held Swiss pharmaceutical company Mepha AG, the companies announced Monday....To view the full article, register now.
Already a subscriber? Click here to view full article